Cargando…

Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD

BACKGROUND: To investigate the short-term outcomes of treatment with intravitreal aflibercept in cases with wet age-related macular degeneration (AMD) resistant to ranibizumab. METHODS: The study included patients who had been undergoing follow-up for a minimum of three months at the Ankara Universi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batioglu, Figen, Demirel, Sibel, Özmert, Emin, Abdullayev, Ahmet, Bilici, Serdar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407797/ https://www.ncbi.nlm.nih.gov/pubmed/25885684 http://dx.doi.org/10.1186/s12886-015-0025-z

Ejemplares similares

Evaluation of Ganglion Cell-Inner Plexiform Layer Thickness after Vitreoretinal Surgery with Internal Limiting Membrane Peeling in Cases with Idiopathic Macular Hole
por: Demirel, Sibel, et al.
Publicado: (2017)

A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy
por: Yanık, Özge, et al.
Publicado: (2022)

Short-term Efficacy of Micropulse Yellow Laser in Non-center-involving Diabetic Macular Edema: Preliminary Results
por: Değirmenci, Mehmet Fatih Kağan, et al.
Publicado: (2018)

Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy
por: Özmert, Emin, et al.
Publicado: (2016)

Multimodal Imaging in Pachychoroid Neovasculopathy: A Case Report
por: Biçer, Özlem, et al.
Publicado: (2018)

Pseudophakic macular edema involving epiretinal proliferation associated with macular hole
por: Batıoğlu, Figen, et al.
Publicado: (2020)

Association Between Optical Coherence Tomography Angiography Findings and Inner Retinal Thickness in Diabetic Patients
por: Temel, Emine, et al.
Publicado: (2022)

Clinical Use of Optical Coherence Tomography Angiography in Retinal Diseases
por: Batıoğlu, Figen, et al.
Publicado: (2023)

The Diagnostic Role of Multimodal Imaging Techniques in Isolated Foveal Hypoplasia
por: Batıoğlu, Figen, et al.
Publicado: (2017)

A Case of Best Disease Accompanied by Pachychoroid Neovasculopathy
por: Batıoğlu, Figen, et al.
Publicado: (2019)

Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
por: Yanık, Özge, et al.
Publicado: (2022)

A Comparative Study of Choroidal Vascular and Structural Characteristics of Typical Polypoidal Choroidal Vasculopathy and Polypoidal Choroidal Neovascularization: OCTA-Based Evaluation of Intervortex Venous Anastomosis
por: Batıoğlu, Figen, et al.
Publicado: (2022)

Visualization of Type-1 Macular Neovascularization Secondary to Pachychoroid Spectrum Diseases: A Comparative Study for Sensitivity and Specificity of Indocyanine Green Angiography and Optical Coherence Tomography Angiography
por: Demirel, Sibel, et al.
Publicado: (2022)

Retinal Vascular Tortuosity Index Change after Idiopathic Epiretinal Membrane Surgery: Does Internal Limiting Membrane Peeling Affect Retinal Vascular Tortuosity?
por: Yanık, Özge, et al.
Publicado: (2023)

Unusual presentation of multiple evanescent white dot syndrome and importance of optical coherence tomography angiography to diagnose choroidal neovascularization under inflammed choriocapillaris
por: Demirel, Sibel, et al.
Publicado: (2020)

Anti-VEGF Treatment Strategies for Wet AMD
por: Kovach, Jaclyn L., et al.
Publicado: (2012)

Optic Coherence Angiography Findings in Type-2 Macular Telangiectasia
por: Nalcı, Hilal, et al.
Publicado: (2017)

Enhanced visualization of acute macular neuroretinopathy by infrared imaging and spectral optical coherence tomography
por: Özmert, Emin, et al.
Publicado: (2013)

Endoscope-Assisted and Controlled Argus II Epiretinal Prosthesis Implantation in Late-Stage Retinitis Pigmentosa: A Report of 2 Cases
por: Özmert, Emin, et al.
Publicado: (2016)

Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting
por: Granstam, Elisabet, et al.
Publicado: (2021)

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
por: Reid, Christopher A., et al.
Publicado: (2018)

One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents
por: Coney, Joseph M, et al.
Publicado: (2023)

Short-Term Morphofunctional Changes in Previously Treated Neovascular AMD Eyes Switched to Brolucizumab
por: Viggiano, Pasquale, et al.
Publicado: (2022)

Bevacizumab in Wet AMD treatment: A tribute to the thirteen years of experience from the beginning of the anti-VEGF era in Romania
por: Stanca, Horia T., et al.
Publicado: (2019)

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
por: Holz, F G, et al.
Publicado: (2016)

Epimacular brachytherapy for wet AMD: current perspectives
por: Casaroli-Marano, Ricardo P, et al.
Publicado: (2014)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
por: Yerramothu, Praveen
Publicado: (2018)

Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD
por: Moraru, Andreea, et al.
Publicado: (2017)

Subretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD
por: Tognetto, Daniele, et al.
Publicado: (2011)

Aflibercept in wet AMD: specific role and optimal use
por: Semeraro, F, et al.
Publicado: (2013)

Improving treatment provision of Wet AMD with intravitreal ranibizumab
por: Ghazala, Fadi, et al.
Publicado: (2013)

Aqueous humor cytokine profiling in patients with wet AMD
por: Liu, Fang, et al.
Publicado: (2016)

Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)
por: Reeves, Barnaby C, et al.
Publicado: (2011)

New Therapies of Neovascular AMD beyond Anti-VEGF Injections
por: Gahn, Greggory M., et al.
Publicado: (2018)

Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis
por: Wu, Mingxing, et al.
Publicado: (2017)

“What should I inject next?” Challenging treatment decisions in the multiple anti-VEGF: a review of publications exploring anti-VEGF switching for nAMD
por: Pikkel, Joseph, et al.
Publicado: (2017)

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD
por: Chakravarthy, Usha, et al.
Publicado: (2021)

Through the Eyes of Patients: Understanding Treatment Burden of Intravitreal Anti-VEGF Injections for nAMD Patients in Norway
por: Reitan, Gudrun, et al.
Publicado: (2023)

Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
por: Waizel, Maria, et al.
Publicado: (2017)

Expression of VEGFA‐regulating miRNAs and mortality in wet AMD
por: Blasiak, Janusz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8mino868g2n88bm9fpmjchrsv7